Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data.


Autoria(s): Zinkstok S.M.; Vergouwen M.D.; Engelter S.T.; Lyrer P.A.; Bonati L.H.; Arnold M.; Mattle H.P.; Fischer U.; Sarikaya H.; Baumgartner R.W.; Georgiadis D.; Odier C.; Michel P.; Putaala J.; Griebe M.; Wahlgren N.; Ahmed N.; van Geloven N.; de Haan R.J.; Nederkoorn P.J.
Data(s)

2011

Resumo

Background and Purpose-The safety and efficacy of thrombolysis in cervical artery dissection (CAD) are controversial. The aim of this meta-analysis was to pool all individual patient data and provide a valid estimate of safety and outcome of thrombolysis in CAD.Methods-We performed a systematic literature search on intravenous and intra-arterial thrombolysis in CAD. We calculated the rates of pooled symptomatic intracranial hemorrhage and mortality and indirectly compared them with matched controls from the Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register. We applied multivariate regression models to identify predictors of excellent (modified Rankin Scale=0 to 1) and favorable (modified Rankin Scale=0 to 2) outcome.Results-We obtained individual patient data of 180 patients from 14 retrospective series and 22 case reports. Patients were predominantly female (68%), with a mean +/- SD age of 46 +/- 11 years. Most patients presented with severe stroke (median National Institutes of Health Stroke Scale score=16). Treatment was intravenous thrombolysis in 67% and intra-arterial thrombolysis in 33%. Median follow-up was 3 months. The pooled symptomatic intracranial hemorrhage rate was 3.1% (95% CI, 1.3 to 7.2). Overall mortality was 8.1% (95% CI, 4.9 to 13.2), and 41.0% (95% CI, 31.4 to 51.4) had an excellent outcome. Stroke severity was a strong predictor of outcome. Overlapping confidence intervals of end points indicated no relevant differences with matched controls from the Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register.Conclusions-Safety and outcome of thrombolysis in patients with CAD-related stroke appear similar to those for stroke from all causes. Based on our findings, thrombolysis should not be withheld in patients with CAD. (Stroke. 2011;42:2515-2520.)

Identificador

http://serval.unil.ch/?id=serval:BIB_C1E8D12F9E72

isbn:1524-4628 (Electronic)

pmid:21799165

doi:10.1161/STROKEAHA.111.617282

isiid:000294342800036

Idioma(s)

en

Fonte

Stroke; A Journal of Cerebral Circulation, vol. 42, no. 9, pp. 2515-2520

Palavras-Chave #Brain Ischemia/etiology; Brain Ischemia/therapy; Carotid Artery Diseases/complications; Carotid Artery Diseases/therapy; Female; Humans; Intracranial Hemorrhages/etiology; Intracranial Hemorrhages/therapy; Male; Meta-Analysis as Topic; Stroke/etiology; Stroke/therapy; Thrombolytic Therapy/adverse effects; Thrombolytic Therapy/methods
Tipo

info:eu-repo/semantics/article

article